Second Sight Reports First Quarter 2019 Financial Results

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today reported financial results for the three months ended March 31, 2019. Recent Financial and Corporate Highlights: Announced a plan to accelerate development of the Orion Visual Cortical Prosthesis System (“Orion”) by al

Full Story →